Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01892657 · ClinicalTrials.gov registry record · Phase 4
Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test
A Phase 4 study of Skin Irritation, sponsored by Galderma R&D.
- Completed
- Registry status
- Phase 4
- Development phase
- 128
- Enrollment target
- 1
- Study location
NCT01892657 is a Phase 4 study of Skin Irritation that has completed, run by Galderma R&D. The registered enrollment target is 128 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01892657, a Phase 4 study of Skin Irritation, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 128 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examined the possible sensitization and irritation effects of a moisturizer with sunscreen SPF 50+.
Conditions Studied
Interventions
- DRUG Facial Moisturizer with SPF 50+
Study Locations (1)
Colorado
- Thomas J. Stephens and Associates, Inc. - Colorado Springs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2008-03 |
| Est. Completion | 2008-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01892657
The ClinicalTrials.gov registry entry for NCT01892657 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Skin Irritation appearing as the primary indexed condition, and to 1 intervention - of which Facial Moisturizer with SPF 50+ is the first listed.
NCT01892657 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT01892657 about?
NCT01892657 is a clinical study titled "Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test". This study examined the possible sensitization and irritation effects of a moisturizer with sunscreen SPF 50+.
What is the current status of trial NCT01892657?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 128 participants. The study started on 2008-03. Estimated completion is 2008-08.
What conditions does trial NCT01892657 study?
This clinical trial studies the following conditions: Skin Irritation.
What interventions are being tested in trial NCT01892657?
The interventions under investigation include: Facial Moisturizer with SPF 50+ (DRUG).
Who is sponsoring clinical trial NCT01892657?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01892657 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.